News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,870 Results
Type
Article (49962)
Company Profile (465)
Press Release (677443)
Multimedia
Podcasts (86)
Webinars (13)
Section
Business (210483)
Career Advice (2071)
Deals (36226)
Drug Delivery (109)
Drug Development (85134)
Employer Resources (174)
FDA (16651)
Job Trends (15200)
News (356600)
Policy (33544)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (10)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (11)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (9)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2779)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (84)
Alliances (51634)
ALS (92)
Alzheimer's disease (1433)
Antibody-drug conjugate (ADC) (136)
Approvals (16632)
Artificial intelligence (257)
Autoimmune disease (24)
Automation (14)
Bankruptcy (375)
Best Places to Work (11919)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (350)
Bladder cancer (66)
Brain cancer (27)
Breast cancer (270)
Cancer (2176)
Cardiovascular disease (177)
Career advice (1728)
Career pathing (29)
CAR-T (160)
Cell therapy (450)
Cervical cancer (20)
Clinical research (68601)
Collaboration (830)
Compensation (496)
Complete response letters (26)
COVID-19 (2720)
CRISPR (44)
C-suite (237)
Cystic fibrosis (104)
Data (2069)
Decentralized trials (2)
Denatured (29)
Depression (48)
Diabetes (259)
Diagnostics (6499)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (126)
Drug pricing (106)
Drug shortages (27)
Duchenne muscular dystrophy (95)
Earnings (87888)
Editorial (37)
Employer branding (21)
Employer resources (148)
Events (116678)
Executive appointments (688)
FDA (17827)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (742)
Gene editing (111)
Generative AI (21)
Gene therapy (321)
GLP-1 (739)
Government (4555)
Grass and pollen (4)
Guidances (50)
Healthcare (19356)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (27)
Infectious disease (2862)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (91)
Interviews (324)
IPO (16864)
IRA (43)
Job creations (3734)
Job search strategy (1465)
Kidney cancer (10)
Labor market (35)
Layoffs (500)
Leadership (17)
Legal (8075)
Liver cancer (75)
Lung cancer (322)
Lymphoma (141)
Machine learning (4)
Management (58)
Manufacturing (296)
MASH (66)
Medical device (13573)
Medtech (13578)
Mergers & acquisitions (19856)
Metabolic disorders (688)
Multiple sclerosis (76)
NASH (19)
Neurodegenerative disease (99)
Neuropsychiatric disorders (30)
Neuroscience (1977)
NextGen: Class of 2025 (6837)
Non-profit (4614)
Northern California (2534)
Now hiring (37)
Obesity (373)
Opinion (226)
Ovarian cancer (76)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (150)
Partnered (20)
Patents (221)
Patient recruitment (102)
Peanut (48)
People (59022)
Pharmaceutical (90)
Pharmacy benefit managers (19)
Phase I (21572)
Phase II (30230)
Phase III (22394)
Pipeline (1125)
Policy (132)
Postmarket research (2662)
Preclinical (9434)
Press Release (70)
Prostate cancer (99)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (399)
Real estate (6109)
Recruiting (67)
Regulatory (23002)
Reports (46)
Research institute (2510)
Resumes & cover letters (360)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (73)
Series A (134)
Series B (85)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2200)
Special edition (17)
Spinal muscular atrophy (157)
Sponsored (30)
Startups (3788)
State (2)
Stomach cancer (16)
Supply chain (64)
Tariffs (16)
The Weekly (55)
United States (22421)
Vaccines (705)
Venture capitalists (38)
Weight loss (251)
Women's health (36)
Worklife (16)
Date
Today (58)
Last 7 days (476)
Last 30 days (2523)
Last 365 days (34394)
2025 (9093)
2024 (36671)
2023 (41368)
2022 (52662)
2021 (57162)
2020 (55395)
2019 (47952)
2018 (36139)
2017 (33593)
2016 (33046)
2015 (39131)
2014 (32927)
2013 (28280)
2012 (30297)
2011 (30732)
2010 (28849)
Location
Africa (763)
Alabama (56)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (40376)
Australia (6909)
California (5840)
Canada (1928)
China (498)
Colorado (260)
Connecticut (272)
Delaware (137)
Europe (89253)
Florida (853)
Georgia (198)
Idaho (58)
Illinois (528)
India (24)
Indiana (301)
Iowa (10)
Japan (151)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (70)
Maryland (872)
Massachusetts (4490)
Michigan (215)
Minnesota (384)
Mississippi (2)
Missouri (79)
Montana (29)
Nebraska (26)
Nevada (57)
New Hampshire (66)
New Jersey (1664)
New Mexico (31)
New York (1653)
North Carolina (1011)
North Dakota (8)
Northern California (2534)
Ohio (197)
Oklahoma (14)
Oregon (37)
Pennsylvania (1302)
Puerto Rico (11)
Rhode Island (30)
South America (1159)
South Carolina (18)
South Dakota (1)
Southern California (2200)
Tennessee (96)
Texas (874)
Utah (172)
Virginia (142)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (51)
727,870 Results for "cell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
March 17, 2025
·
2 min read
·
Tristan Manalac
Deals
AbbVie Triples Down on T Cell Therapies in Xilio Deal Worth Up to $2.1B
The pharma giant inked its third T cell engager deal of 2025 Wednesday—this time with Xilio Therapeutics for tumor-activated immunotherapies.
February 12, 2025
·
1 min read
·
Kate Goodwin
Press Releases
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
March 27, 2025
·
8 min read
Press Releases
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
February 12, 2025
·
9 min read
Biotech Bay
EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools
EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools.
June 27, 2024
·
2 min read
Business
Adaptimmune Raises ‘Substantial Doubt’ About Business Despite First-in-Class T Cell Therapy
Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its approval in August 2024. Nevertheless, it is pausing development of two oncology assets to save money.
March 21, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
February 12, 2025
·
6 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
1 of 72,787
Next
